Possible beneficial effects of soy protein on the vascular endothelium in postmenopausal women - Future directions

Israel Medical Association Journal

Volumn 5, Issue 1, 2003, Pages 56-58

  Blum, Arnon ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Postmenopause; Soy protein; Vascular endothelium

Indexed keywords

ACETYLCHOLINE; COUMESTAN DERIVATIVE; DAIDZEIN; ENDOTHELIN 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR INHIBITOR; FLAVONE DERIVATIVE; GENISTEIN; HORMONE RECEPTOR BLOCKING AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHYTOESTROGEN; SOYBEAN PROTEIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR EFFECT; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; COLON CANCER; DIET; DISEASE CONTROL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HEART PROTECTION; HUMAN; INCIDENCE; INHIBITION KINETICS; ISCHEMIC HEART DISEASE; NONHUMAN; POPULATION RESEARCH; POSTMENOPAUSE; PROSTATE CANCER; REVIEW; SIDE EFFECT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ENDOTHELIUM, VASCULAR; ESTROGENS, NON-STEROIDAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; ISOFLAVONES; NF-KAPPA B; NITRIC OXIDE; PHYTOESTROGENS; PLANT PREPARATIONS; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 0037272885     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Grodstein F, Stampfer M, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336(25):1769-76.
2. Grodstein F, Stampfer M, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335(7):453-61.
3. Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786-91.
4. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-551.
5. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41.
6. Colditz GA, Stampfer MJ, Willett WC, et al. Prospective study of estrogen replacement therapy and risk of breast cancer in women. JAMA 1990;264:2648-53.
7. Terpstra AH, Wers CE, Ferris JT, Schouten JA, Van Der Veen EA. Hypocholesterolemic effect of dietary soy protein versus casein in rhesus monkeys (Macaca mulatta). Am J Clin Med 1984;39:1-7.
8. Lovati MR, Gaddi G, Sirtori CR. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987;80:1498-502.
9. Clarkson TB, Anthony MS, Hughes CL. Estrogenic soybean isoflavones and chronic disease. Risks and benefits. Trend Endocrinol Metab 1995;6:11-16.
10. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-50.
11. Karas RH, Baur WE, Van Eickles M, et al. Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Lett 1995;377:103-8.
12. Kim-Schulze S, McGowan KA, Hubchak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996;94:1402-7.
13. Roque M, Heras M, Roig E, et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998;31:139-43.
14. Reis SE, Gloth ST, Blumenthal RS, et al. Estradiol acutely attenuates coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
15. Herrington DM, Braden GA, Wiliams JK, et al. Endothelium-dependent coronary vasocomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 1994;73:951-2.
16. Collins P, Rosano GM, Sarrel PM, et al. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:27-30.
17. Guetta V, Quyyumi AA, Prasad A, et al. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997;96:2795-801.
18. Best PJM, Berger PB, Miller VM, et al. The effects of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998;128:285-8.
19. Ylikorkala O, Orpana A, Puolakka J, et al. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 1995;80:3384-7.
20. Hishikawa K, Nakaki T, Marumo T, et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995;360:291-3.
21. Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995;214:847-55.
22. Caulin-Glaser TL, Garcia-Cardena G, Sarrel P, et al. The effect of 17-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca mobilization [Abstract]. Circulation 1994;90(Suppl 1):1-30.
23. Venema RC, Nishida K, Alexander RW, et al. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1993;1218:413-20.
24. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
25. Peng HB, Rajarashisth TB, Libby P, et al. Nitric oxide inhibits macrophage-colony stimulating factor gene expression in vascular endothelial cells. J Cell Chem 1995;270:17050-5.
26. Zeiher AM, Fisslthaler B, Schray-Ulz B, et al. Nitric oxide modulates the expression of monocyte chemoattractant protein-1 in cultured human endothelial cells. Circ Res 1995;76:980-6.
27. Berliner PA, Watson AD, Lusis AJ. Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics. Circulation 1995;91:2488-96.
28. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-74.
29. Keaney JF, Shwaery GT, Xu A, et al. 17b-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994;89:2251-9.
30. Sack MN, Rader DJ, Cannon RO III. Estrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
31. Sorensen KE, Dorup I, Hermann AP, et al. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234-8.
32. McCrohon JA, Adams MR, Robyn J, et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol 1996;45:435-41.
33. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors on postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. The writing group for the PEPI trial. JAMA 1995;273(3):199-208.
34. Anderson JW, Johnstone BM. Meta analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
35. Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 1999;70:464-74S.
36. Brandi ML. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Calcif Tissue Int 1997;61:S5-8.
37. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1987;103:1860-7.